It is a bitter disappointment for people with amyotrophic lateral sclerosis (ALS) and their families. The drug AMX0035 (trade name: Relyvrio) was seen as a beacon of hope against the serious and fatal nerve disease that gradually paralyzes the body and for which there is currently no cure. But according to the manufacturer, the results of the final phase of clinical testing are now available – and they are devastating.
Drug against ALS not effective after all – health
